Laxmi Organic Industries Limited has released its unaudited financial results for the third quarter and nine months ended December 31, 2025, revealing a challenging operational environment with declining revenues and profitability metrics. The company also conducted an investor conference call on January 30, 2026, providing detailed insights into market conditions and strategic initiatives.

Financial Performance Overview

The company's standalone financial performance for Q3FY26 showed notable declines across key metrics compared to the previous year:

The consolidated results showed a similar trend, with revenue from operations declining to ₹7,186.82 million from ₹7,863.35 million in Q3FY25, representing an 8.6% decrease. EBITDA for the quarter stood at nearly ₹50 crores, down 33% compared to the previous year.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, the company's performance reflected sustained pressure:

Market Challenges and Business Segment Performance

During the earnings call, Managing Director and CEO Dr. Rajan Venkatesh highlighted that the global chemical industry continues to face challenges with ongoing cost optimization efforts, shutdowns, and supply chain restructuring. The company's Essentials business saw revenue decline by 6% while maintaining volumes, primarily due to acetic acid feedstock price impacts. The Specialties segment experienced a more significant 30% revenue decline attributed to price moderation (12%), absence of one-time campaign products from the previous year (5-6%), and the phaseout of agrochemical intermediates (10%).

Significant Operational Developments

The company implemented several important changes during the reporting period. A key development was the change in depreciation method from written down value to straight line method, resulting in lower depreciation expenses. Under the previous method, depreciation for Q3FY26 would have been higher by ₹288.97 million.

Additionally, Laxmi Organic reversed accrued liabilities of ₹407.27 million related to wheeling losses, wheeling charges, transmission losses and transmission charges levied by Maharashtra State Electricity Distribution Company Limited, based on a favorable order from MERC.

Project Updates and Strategic Initiatives

The Dahej facility represents the company's largest capex investment, with Phase 1 already online and Phase 2 focusing on diketene, ketene, and downstream derivatives expected to complete mechanical work by quarter-end. The company anticipates FY27 as the first year of qualification and ramp-up, with accelerated growth in FY28.

Corporate Governance and Regulatory Updates

The Board approved the re-appointment of Dr. Rajiv Banavali as an Independent Director for a second term from May 18, 2026, to May 17, 2028. The company exercised the option under Section 115BBA of the Income Tax Act to compute income tax at 25.17%, resulting in a deferred tax liability reversal of ₹97.18 million. Following new Labour Codes notification, the company recognized ₹38.02 million toward increased gratuity liability and compensated absences.

Market Outlook and Recovery Signals

Management noted early signs of improvement in key feedstock pricing, particularly acetic acid, which had declined over 20% in the past two years but recently rebounded from $320-330 levels to $360-380 range. The company expects ethyl acetate spreads to improve from the previous pain point of $90-100 to approximately $130 range. Demand signals from packaging, inks and adhesives remained stable, while agrochemicals showed moderate demand and pharmaceuticals remained stable.

Source: Earnings call transcript and financial results

Laxmi Organic Industries Limited has filed a regulatory intimation confirming no deviation in the utilization of Qualified Institutions Placement (QIP) proceeds for the quarter ended December 31, 2025. The company submitted its compliance report to BSE and NSE on February 4, 2026, along with the monitoring agency report issued by India Ratings & Research Private Limited.

QIP Issue Details and Current Status

The company's QIP was conducted from October 5, 2023, to October 10, 2023, raising INR 2,591.21 million through the issuance of 9,625,579 equity shares at INR 269.20 per share. The monitoring agency report confirms that all utilization remains aligned with the objects stated in the placement document dated October 10, 2023.

Project-wise Utilization and Reallocation

The company has made significant progress across its funded projects, with notable completion of the Mahape innovation center. The monitoring report reveals a strategic reallocation of funds following project completion and cost optimization.

Mahape Project Completion and Fund Reallocation

The Mahape innovation center project achieved completion with cost savings of INR 109.58 million against the original estimate. The 2,100 square meter facility is designed to scale R&D efforts in line with growing manufacturing sites and product pipeline. Following project completion, the Board approved reallocation of the saved amount to the Dahej project on October 29, 2025, subsequently ratified by shareholders through postal ballot on December 6, 2025.

Dahej Manufacturing Facility Progress

The Dahej manufacturing facility project continues as an ongoing initiative, with INR 1,511.42 million utilized out of the revised allocation of INR 1,729.24 million. The facility, spread across 84.71 acres in Bharuch, Gujarat, represents the company's expansion strategy to add manufacturing capacity and provide geographic diversification from the existing Mahad facilities.

Deployment of Unutilized Proceeds

The company has deployed the unutilized QIP proceeds of INR 217.82 million in liquid investments to optimize returns while maintaining liquidity for ongoing project requirements.

Note: Total includes unutilized proceeds of INR 217.82 million plus returns of INR 6.75 million

Regulatory Compliance and Monitoring

The monitoring agency report confirms that all statutory requirements under SEBI regulations have been met, with no material deviations observed. The company has obtained necessary government approvals for current project stages, with the Dahej project timeline extended to June 30, 2026, following Board and shareholder approvals. The comprehensive monitoring framework ensures transparent utilization of investor funds in accordance with disclosed objectives.